Navigation Links
Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
Date:8/12/2008

Owing to Well-Established and Effective Insulin-Based Therapies, Market Growth Will be Modest Through 2017, According to a New Report from Decision

Resources

WALTHAM, Mass., Aug. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the most significant driver of growth in the type 1 diabetes market will be the shift in the standard of care away from regular human insulins and neutral protamine Hagedorn (NPH) insulin to more-expensive rapid-acting insulin analogues and long-acting insulin analogues. Short-acting insulin analogues provide a more rapid onset of action than regular human insulin and long-acting insulin analogues require fewer injections than NPH insulin.

The new Pharmacor report entitled Type 1 Diabetes finds that market growth will be driven by rapid-acting insulin analogues that include Novo Nordisk's Novorapid/Novolog and Eli Lilly's Humalog as well as long-acting insulin analogues that include Sanofi-Aventis's Lantus and Novo Nordisk's Levemir. Since the type 1 diabetes market is saturated with effective and well-established insulin-based therapies that have been in use for decades, the report forecasts only modest 1.2 percent annual market growth through 2017.

According to the report, novel devices designed to allow needle-free administration of insulin could revolutionize treatment of type 1 diabetes, but their uptake will be hampered by physicians' negative experience with Pfizer/Nektar's inhaled insulin, Exubera, which fared poorly in the market owing to safety concerns and its premium price. Among the insulin-based therapies currently in the pipeline for type 1 diabetes, oral and transdermal insulins hold the greatest promise but their use will be constrained by dosing variability issues that are likely to dissuade physicians from prescribing them.

The report also finds that novel immu
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
2. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
3. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
4. Treatment Corrects Severe Insulin Imbalance in Animal Studies
5. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
8. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
9. Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., BATESVILLE, Ind. and MCDONOUGH, Ga., Nov. 9 /PR...d Encompass Group today announced the formation of...istribution of a comprehensive range of surface re...arate from a bed frame and as replacements for sur...end of their useful life. Hill-Rom, a global lead...
(Date:11/9/2009)..., ,, PRINCETON, N.J., Nov. 9 /PRNewswire...nnounces management will present at the Sixth Annu...he conference will be held at the St Regis Hotel i...efer Price, Pharmasset,s President and Chief Execu...any on Wednesday, November 18, 2009 at 3:45 PM (ET...
(Date:11/9/2009)..., HOUSTON, Nov. 9 Patent attorne...tipkala, Ph.D., J. D., will showcase Stipkala LLC ...3, 2009, which will be held at the Institute of Mo...cience Conference provides a platform for cutting-...ties to investors, and will feature keynote addres...
Breaking Medicine Technology:Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 1Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 2Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 3Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 1Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 2
...,Contributing Editor , ,Positive patient ide...editing bodies for the past few years. Until rece...are were beyond the reach of the average hospital ...ith devices that can be integrated into a facility...ter for small facilities, while others are best fo...
...vard Medical School ,Contributing Editor , ,...per year, breast cancer undoubtedly qualifies as o...ntly, efforts to develop early detection methods a...ress. This is particularly true at the molecular ...e translated into new diagnostic tests and targete...
Other Medicine Technology:Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3
(Date:11/9/2009)...GTON, Nov. 9 The Churchill Centr...d For Leadership to J.W. "Bill" Marriott for his l...progressive free market practices and fostering an... Marriott will receive his award at a ceremony and...D.C. Four Seasons Hotel. ,, "This is a testame...
(Date:11/9/2009)...e left atrial enlargement, study finds , ... major risk factor for left atrial enlargement, wh...oke and death, a new study shows. , Atrial fibr... irregular heart rhythm or heartbeat). , Resea...25 to 74, in Germany who were followed for 10 year...
(Date:11/9/2009)...due to fact that both eye conditions are age-relat...HealthDay News) -- Cataract surgery doesn,t appear...egeneration (AMD), according to a new study that c...sion loss worsens the other. , "Because both co...s with cataract also have AMD," wrote Li Ming Dong...
(Date:11/9/2009)...are increases with longer doctor visits, researche...s) -- Family doctors are now taking more time cons... and improving the quality of visits, a new study ...r primary care physicians during office visits in ...erall they seemed to receive better care," said Dr...
(Date:11/9/2009)... Course, to be Offered in April 2010,... , Cambridge, MA (Vocus) ...ans for Human Rights (PHR) first inspected a suspe... he realized he would need a team of experts to he...he site properly was a key first step in securing ...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...n worms are shedding new light on the hormone,s ro...lthDay News) -- Scientists have gained new insight...the groundwork for an anti-aging treatment. , The...s whose insulin levels were adjusted lived a week ...
...nati, OH March 20, 2008 In workplaces where nurs...es, the health of nurses suffers, and the retentio...le published in the Journal of Obstetric, Gynecolo... environment. , More than half of nurses surveye...
...gton, DC, March 20, 2008 -- The Association for Pr...(APIC) today announced a detailed strategy to comb.... The initiative begins with the first national pr...rrhea and more serious intestinal conditions such ...
...as appeared among Hispanic Enterprise,s best compa...nce 2005, COLUMBUS, Ga., March 20 Aflac Incorpor... supplier diversity list by Hispanic,Enterprise ma...ase and are,committed to the economic prosperity i...
... March 20, 2008 A bodysuit that heats or cools a...ye movements, is providing multiple sclerosis rese...ew tool to study the mysterious link between body ...ho reported in 1889 that some people have temporar...
...PARK, Kan., March 20 A recent outbreak of,Eastern...rong reminder to,horse owners throughout the count...r dangerous mosquito-borne diseases. To ensure you...at protects,against West Nile virus, EEE and Weste...
Other Medicine News:Health News:Tweaking Insulin Might Help Fight Aging 2Health News:APIC launches first national C. difficile prevalence study 2Health News:Aflac Named Among the 50 Best Companies for Supplier Diversity 2Health News:Eye test peers into heat-related multiple sclerosis symptoms 2Health News:Fort Dodge's 'Mosquito Shot' Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses 2
Thyroglobulin Autoantibody - ELISA
Coat-a-Count Estradiol RIA
... the quantitative determination of Estradiol (E2) ...(E2) is a C18 steroid hormone with a phenolic A ri...f 272.4. It is the most potent natural Estrogen, ...ller amounts by the adrenal cortex, and the male t...
AxSYM Troponin-I ADV
Medicine Products: